Cita APA (7a ed.)

University, F. A. H. o. G. M. (2026). Targeting the NSUN5-circPPAP2A axis reverses immunosuppression and sensitizes renal cell carcinoma to anti-PD-1 therapy. Zenodo.

Cita Chicago Style (17a ed.)

University, First Affiliated Hospital of Guangzhou Medical. Targeting the NSUN5-circPPAP2A Axis Reverses Immunosuppression and Sensitizes Renal Cell Carcinoma to Anti-PD-1 Therapy. Zenodo, 2026.

Cita MLA (9a ed.)

University, First Affiliated Hospital of Guangzhou Medical. Targeting the NSUN5-circPPAP2A Axis Reverses Immunosuppression and Sensitizes Renal Cell Carcinoma to Anti-PD-1 Therapy. Zenodo, 2026.